Bio-pharmaceutical company raises 150 million USD from Chinese investors
In a sign that China’s dedication to boosting its domestic healthcare industry remains as strong as ever, three Chinese investment firms have recently announced a 150 million USD investment in CStone Pharmaceuticals Co., Ltd., a bio-pharmaceutical company that is developing new treatments for major diseases. The research-based company was founded in Shanghai and Suzhou. Its…